Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication

被引：2
|
作者：
Ma, Yanlei [1 ]
Qin, Huanlong [1 ]
Zheng, Qi [1 ]
Wang, Yu [1 ]
Wang, Zhiguo [1 ]
Yang, Zhe [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Peoples Hosp Affiliated 6, Dept Surg, Shanghai 200233, Peoples R China
来源：
MEDICAL ONCOLOGY | 2010年 / 27卷 / 04期
关键词：
Neoadjuvant chemotherapy; Nonresectable advanced gastric cancer; Docetaxel; Cisplatin; Fluorouracil; Leucovorin; PHASE-II; PLUS FLUOROURACIL; RANDOMIZED-TRIAL; 1ST-LINE THERAPY; D2; GASTRECTOMY; CARCINOMA; ADENOCARCINOMA; SURVIVAL; STRATEGIES; ETOPOSIDE;
D O I：
10.1007/s12032-009-9340-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of this study was to evaluate the efficacy and toxicity of docetaxel (TAX), cisplatin (CDDP), and fluorouracil (5-FU) plus leucovorin (CF) as the neoadjuvant chemotherapy (NACT) regimens in the treatment of nonresectable advanced gastric cancer. Twelve patients with nonresectable advanced gastric cancer were treated with NACT regimens consisted of docetaxel, cisplatin, fluorouracil, plus leucovorin before operation. Nine of the 12 patients were downstaged and 8 were radically operated after the end of the NACT. The overall response rate was 75% with 8.3% complete response and 66.7% partial response, and the ascites disappeared in 63.6%. The most common toxicities were bone marrow suppression, nausea, vomiting, alopecia, and heptoses. The toxicities were recoverable after symptomatic treatment. The results confirmed that the combination of docetaxel, cisplatin, fluorouracil plus leucovorin (CF) is a very effective and well-tolerated regimen as NACT for the patients with nonresectable advanced gastric cancer.
引用
收藏
页码：1089 / 1095
页数：7
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication
    Yanlei Ma
    Huanlong Qin
    Qi Zheng
    Yu Wang
    Zhiguo Wang
    Zhe Yang
    Medical Oncology, 2010, 27 : 1089 - 1095
  • [2] NEOADJUVANT CHEMOTHERAPY WITH A COMBINATION OF S-1 AND CISPLATIN IN NONRESECTABLE ADVANCED GASTRIC CANCER: A SHORT COMMUNICATION
    Kosaka, T.
    Hosokawa, K.
    Yokoi, M.
    Kinami, S.
    Omote, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 117 - 117
  • [3] Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
    S C Oh
    K H Park
    I K Choi
    S Y Yoon
    S J Kim
    J H Seo
    C W Choi
    B S Kim
    S W Shin
    J S Kim
    Y H Kim
    British Journal of Cancer, 2005, 92 : 827 - 831
  • [4] Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
    Oh, SC
    Park, KH
    Choi, IK
    Yoon, SY
    Kim, SJ
    Seo, JH
    Choi, CW
    Kim, BS
    Shin, SW
    Kim, JS
    Kim, YH
    BRITISH JOURNAL OF CANCER, 2005, 92 (05) : 827 - 831
  • [5] Docetaxel, cisplatin, UFT and leucovorin combination chemotherapy in advanced gastric cancer.
    Oh, SC
    Sung, S
    Park, G
    Choi, I
    Seo, JH
    Choi, C
    Kim, B
    Shin, S
    Kim, Y
    Kim, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 371S - 371S
  • [6] Treatment of Borrmann Type IV Gastric Cancer with a Neoadjuvant Chemotherapy Combination of Docetaxel, Cisplatin and 5-Fluorouracil/Leucovorin
    Sun, X-C
    Lin, J.
    Ju, A-H
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (06) : 2096 - 2102
  • [7] Neoadjuvant chemotherapy with Cisplatin, Leucovorin and 5 Fluorouracil (PLF) for locally advanced gastric cancer
    Grundel, T
    Fink, U
    Matzen, K
    Sendler, A
    Feussner, H
    Dittler, H
    Becker, K
    Helmberger, H
    Siewert, JR
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1323 - 1326
  • [8] The combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer
    Guo, Ming-Gao
    Zheng, Qi
    Cheng, Zhe
    Wang, Yu
    Feng, Chang-Ning
    Yang, Zhe
    SURGICAL ONCOLOGY-OXFORD, 2010, 19 (01): : 1 - 3
  • [9] Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer
    Ridwelski, K
    Gebauer, T
    Fahlke, J
    Kröning, H
    Kettner, E
    Meyer, F
    Eichelmann, K
    Lippert, H
    ANNALS OF ONCOLOGY, 2001, 12 (01) : 47 - 51
  • [10] Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer
    Janinis, J
    Panagos, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1393 - 1394
12345